Tas-102 for Refractory Metastatic Colorectal Cancer: A Multicenter Retrospective Cohort Study

Tas-102 for Refractory Metastatic Colorectal Cancer: A Multicenter Retrospective Cohort Study

Trifluridine/tipiracil (TAS-102) is an oral chemotherapy approved for the treatment of metastatic colorectal cancer. The efficacy and tolerability of TAS-102 were shown in phase II-III clinical trials and in several real-life studies. The elderly and other special subgroups are underrepresented in p...

Full description

Bibliographic Details
Main Authors: Matteo Conti, Elena Bolzacchini, Giovanna Luchena, Lorenza Bertu’, Paola Tagliabue, Stefania Aglione, Antonio Ardizzoia, Jessica Arnoffi, Francesco Maria Guida, Alessandro Bertolini, Alessandro Pastorini, Maria Duro, Donato Bettega, Giovambattista Roda’, Salvatore Artale, Alessandro Squizzato, Monica Giordano
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Cancers
Subjects:
TAS-102
mCRC
DPYD
HIV
elderly
Online Access:https://www.mdpi.com/2072-6694/15/13/3465

Internet

https://www.mdpi.com/2072-6694/15/13/3465

Similar Items